Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
Anti-Cancer Agents in Medicinal Chemistry|August 12, 2021
Alkylating Agents, the Road Less Traversed, Changing Anticancer TherapyDipanjan Karati, Kakasaheb Ramoo Mahadik, Piyush Trivedi, et al.Current Cancer Drug Targets|March 2, 2022
The Emerging Role of Janus Kinase Inhibitors in the Treatment of CancerDipanjan Karati, Kakasaheb Ramoo Mahadik, Piyush Trivedi, et al.Journal of Labelled Compounds & Radiopharmaceuticals|June 4, 2014
Topical delivery of fluorescence (6-Cf) labeled and radiolabeled (99m-Tc) cisplatin and imiquimod by a dual drug delivery systemVandana Gupta, Krishna Chuttani, Anil K Mishra, et al.Acta Poloniae Pharmaceutica|December 5, 2008
Analgesic and anti-inflammatory activities of Trigonella foenum-graecum (seed) extractSavita Vyas, Rajendra Prasad Agrawal, Pooja Solanki, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 18, 2010
Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivativesN S Hari Narayana Moorthy, C Karthikeyan, Piyush TrivediMedicinal Chemistry (Shariqah (United Arab Emirates))|March 4, 2022
A Molecular Insight into Pyrazole Congeners as Antimicrobial, Anticancer, and Antimalarial AgentsDipanjan Karati, Kakasaheb Ramoo Mahadik, Piyush Trivedi, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|January 1, 2010
Synthesis, cytotoxic evaluation and in silico pharmacokinetic prediction of some benzo[a]phenazine-5-sulfonic acid derivativesN S Hari Narayana Moorthy, C Karthikeyan, Piyush TrivediJournal of Enzyme Inhibition and Medicinal Chemistry|November 18, 2008
QSAR study of substituted 2-pyridinyl guanidines as selective urokinase-type plasminogen activator (uPA) inhibitorsC Karthikeyan, N S Hari Narayana Moorthy, Piyush TrivediJournal of Liposome Research|December 17, 2013
Development of novel topical drug delivery system containing cisplatin and imiquimod for dual therapy in cutaneous epithelial malignancyVandana Gupta, Vipin Dhote, Bhola Nath Paul, et al.Anti-Cancer Agents in Medicinal Chemistry|June 16, 2022
Molecular Insights on Selective and Specific Inhibitors of Cyclin Dependent Kinase 9 Enzyme (CDK9) for the Purpose of Cancer TherapyDipanjan Karati, Kaka Saheb Ramoo Mahadik, Piyush Trivedi, et al.Pageof 7